Janux Therapeutics, Inc. (JANX) Tops Q4 EPS by 11c

Janux Therapeutics, Inc. (NASDAQ: JANX) reported Q4 EPS of ($0.51), $0.11 better than the analyst estimate of ($0.62).

For earnings history and earnings-related data on Janux Therapeutics, Inc. (JANX) click here.

You May Also Be Interested In

• Casey's General Stores (CASY) Tops Q1 EPS by 69c
• Activist investor presses Xerox to review financial services arm - Bloomberg
• Argo Graphene raises private placement target to $1.5M